BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kenig A, Ilan Y. A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment. Front Physiol 2019;10:1542. [PMID: 31920730 DOI: 10.3389/fphys.2019.01542] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Hurvitz N, Azmanov H, Kesler A, Ilan Y. Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. Eur J Hum Genet 2021. [PMID: 34276056 DOI: 10.1038/s41431-021-00928-4] [Reference Citation Analysis]
2 Ilan Y. Why scientists, academic institutions, and investors fail in bringing more products to the bedside: the Active Compass model for overcoming the innovation paradox. J Transl Med 2021;19:55. [PMID: 33541380 DOI: 10.1186/s12967-021-02726-4] [Reference Citation Analysis]
3 Gelman R, Bayatra A, Kessler A, Schwartz A, Ilan Y. Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents. Emerg Microbes Infect 2020;9:1397-406. [PMID: 32490731 DOI: 10.1080/22221751.2020.1776161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
4 Rotnemer-Golinkin D, Ilan Y. Personalized-Inherent Variability in a Time-Dependent Immune Response: A Look into the Fifth Dimension in Biology. Pharmacology 2022;:1-6. [PMID: 35537442 DOI: 10.1159/000524747] [Reference Citation Analysis]
5 Ilan Y. Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects. Mol Ther Methods Clin Dev 2020;18:335-44. [PMID: 32671136 DOI: 10.1016/j.omtm.2020.06.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
6 Ilan Y. Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor. Int J Environ Res Public Health 2021;18:811. [PMID: 33477865 DOI: 10.3390/ijerph18020811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Ishay Y, Potruch A, Schwartz A, Berg M, Jamil K, Agus S, Ilan Y. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomed Pharmacother 2021;143:112228. [PMID: 34649354 DOI: 10.1016/j.biopha.2021.112228] [Reference Citation Analysis]
8 Gelman R, Berg M, Ilan Y. A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review. Int J Environ Res Public Health 2022;19:1722. [PMID: 35162745 DOI: 10.3390/ijerph19031722] [Reference Citation Analysis]
9 Wasyluk W, Zwolak A. PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis. J Inflamm Res 2021;14:1827-44. [PMID: 33986609 DOI: 10.2147/JIR.S300679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ishay Y, Kessler A, Schwarts A, Ilan Y. Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications. Hepatol Commun 2020. [PMID: 32904861 DOI: 10.1002/hep4.1600] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Kolben Y, Weksler‐zangen S, Ilan Y. Adropin as a potential mediator of the metabolic system‐autonomic nervous system‐chronobiology axis: Implementing a personalized signature‐based platform for chronotherapy. Obesity Reviews 2021;22. [DOI: 10.1111/obr.13108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kessler A, Weksler-zangen S, Ilan Y. Role of the Immune System and the Circadian Rhythm in the Pathogenesis of Chronic Pancreatitis: Establishing a Personalized Signature for Improving the Effect of Immunotherapies for Chronic Pancreatitis. Pancreas 2020;49:1024-32. [DOI: 10.1097/mpa.0000000000001626] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Wasyluk W, Zwolak A. Metabolic Alterations in Sepsis. J Clin Med 2021;10:2412. [PMID: 34072402 DOI: 10.3390/jcm10112412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Khoury T, Ilan Y. Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity. Obes Res Clin Pract 2021;15:114-23. [PMID: 33653665 DOI: 10.1016/j.orcp.2021.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Awad A, Madla CM, McCoubrey LE, Ferraro F, Gavins FKH, Buanz A, Gaisford S, Orlu M, Siepmann F, Siepmann J, Basit AW. Clinical translation of advanced colonic drug delivery technologies. Adv Drug Deliv Rev 2022;181:114076. [PMID: 34890739 DOI: 10.1016/j.addr.2021.114076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
16 Ilan Y. Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes. Front Digit Health 2020;2:569178. [DOI: 10.3389/fdgth.2020.569178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kenig A, Kolben Y, Asleh R, Amir O, Ilan Y. Improving Diuretic Response in Heart Failure by Implementing a Patient-Tailored Variability and Chronotherapy-Guided Algorithm. Front Cardiovasc Med 2021;8:695547. [PMID: 34458334 DOI: 10.3389/fcvm.2021.695547] [Reference Citation Analysis]
18 Azmanov H, Bayatra A, Ilan Y. Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects. J Pain Res 2022;15:1051-60. [PMID: 35444460 DOI: 10.2147/JPR.S356319] [Reference Citation Analysis]
19 Potruch A, Khoury ST, Ilan Y. The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs. Seizure 2020;80:201-11. [DOI: 10.1016/j.seizure.2020.06.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Paudel KR, Jha SK, Allam VSRR, Prasher P, Gupta PK, Bhattacharjee R, Jha NK, Vishwas S, Singh SK, Shrestha J, Imran M, Panth N, Chellappan DK, Ebrahimi Warkiani M, Hansbro PM, Dua K. Recent Advances in Chronotherapy Targeting Respiratory Diseases. Pharmaceutics 2021;13:2008. [PMID: 34959290 DOI: 10.3390/pharmaceutics13122008] [Reference Citation Analysis]
21 Ilan Y, Spigelman Z. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. Cancer Treatment and Research Communications 2020;25:100240. [DOI: 10.1016/j.ctarc.2020.100240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Forkosh E, Kenig A, Ilan Y. Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy. Pharmacol Res Perspect 2020;8:e00616. [PMID: 32608157 DOI: 10.1002/prp2.616] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
23 Ilan Y. Digital Medical Cannabis as Market Differentiator: Second-Generation Artificial Intelligence Systems to Improve Response. Front Med 2022;8:788777. [DOI: 10.3389/fmed.2021.788777] [Reference Citation Analysis]
24 Meléndez-Fernández OH, Walton JC, DeVries AC, Nelson RJ. Clocks, Rhythms, Sex, and Hearts: How Disrupted Circadian Rhythms, Time-of-Day, and Sex Influence Cardiovascular Health. Biomolecules 2021;11:883. [PMID: 34198706 DOI: 10.3390/biom11060883] [Reference Citation Analysis]
25 Ilan Y. Order Through Disorder: The Characteristic Variability of Systems. Front Cell Dev Biol 2020;8:186. [PMID: 32266266 DOI: 10.3389/fcell.2020.00186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]